GlassScriptPhysician profile
Lynette R Mehl
NPI 1366443772
$1,615.10
in general payments reported to CMS, 2019-2025
10 companies · $430 in 2025
The $430 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $198 · 2023: $430 · 2024: $439 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,298.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $566.09 | 2023-2025 | Prostep Mica, Prophecy, Citrefix |
| Paratek Pharmaceuticals, INC. | $227.58 | 2023-2024 | Nuzyra |
| Abbott Laboratories | $226.33 | 2022-2025 | Eterna |
| Angiodynamics, INC. | $122.21 | 2024 | Auryon Laser System 100-120 Vac |
| Organogenesis INC. | $118.97 | 2021 | |
| Horizon Therapeutics Plc | $117.39 | 2023 | Krystexxa |
| Stimwave Technologies Incorporated | $101.76 | 2022 | |
| Biotissue Holdings INC. | $87.12 | 2024 | |
| Paragon 28, INC. | $31.26 | 2023 | Plating Portfolio |
| Amgen INC. | $16.39 | 2025 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynette Mehl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.